Chimera Peptides: Engineering Novel Therapeutics
Hybrid peptide sequences represent a promising approach for designing new drug candidates. These kinds of molecules consist of distinct peptide domains originating from unrelated templates, allowing the creation of novel binding characteristics . Such a engineering strategy can overcome challenge